GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

6 Months Ended

Apr. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill balances and movements for each reportable segments during the period

The following table presents goodwill balances and the movements for each of our reportable segments during the six months ended April 30, 2016:



	Life Sciences and Applied Markets		Diagnostics and Genomics		Agilent CrossLab		Total
	(in millions)
Goodwill as of October 31, 2015	$	650	$	1,234	$	482	$	2,366
Foreign currency translation impact	5		44		4		53
Goodwill arising from acquisitions	137		—		—		137
Goodwill as of April 30, 2016	$	792	$	1,278	$	486	$	2,556

Components of other intangibles during the period

The components of other intangibles as of April 30, 2016 and October 31, 2015 are shown in the table below:



	Purchased Other Intangible Assets
	Gross Carrying Amount		Accumulated Amortization and Impairments		Net Book Value
	(in millions)
As of October 31, 2015:
Purchased technology	$	746	$	476	$	270
Trademark/Tradename	141		50		91
Customer relationships	230		168		62
Total amortizable intangible assets	1,117		694		423
In-Process R&D	22		—		22
Total	$	1,139	$	694	$	445
As of April 30, 2016:
Purchased technology	840		535		305
Backlog	1		1		—
Trademark/Tradename	154		57		97
Customer relationships	266		200		66
Total amortizable intangible assets	1,261		793		468
In-Process R&D	22		—		22
Total	$	1,283	$	793	$	490

Schedule of estimated future amortization expense of finite-lived intangible assets

Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2016 and for each of the five succeeding fiscal years and thereafter is estimated below:



Estimated future amortization expense:
(in millions)
Remainder of 2016	$	69
2017	$	113
2018	$	83
2019	$	59
2020	$	48
2021	$	36
Thereafter	$	60